AboutTelix PharmaceuticalsLimited Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with international operations in the United States, Europe (Belgium and Switzerland) and Japan. Telixisdevelopingaportfolioofclinical-stageproducts thataimstoaddress significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX:TLX). Visitwww.telixpharma.comforfurther informationaboutTelix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on Twitter (@TelixPharma) and LinkedIn. TLX250-CDx (89Zr-DFO-girentuximab) has not received a marketing authorisation in any jurisdiction. Telix's lead product, Illuccix or kit for preparation of gallium-68 (68Ga) gozetotide (also known as 68Ga PSMA-11) injection, has been approved by the U.S. Food and Drug Administration (FDA), [11] by the Australian Therapeutic Goods Administration (TGA), [12] and by Health Canada.[13] Telix is also progressing a marketing authorisation application for this investigational candidate in the United Kingdom.[14] Telix InvestorRelations Ms.KyahnWilliamson TelixPharmaceuticalsLimited SVPCorporateCommunicationsandInvestorRelations Email: [email protected] Legal Notices This announcement is not intended as promotion or advertising directed to any healthcare professional or other audience in any country worldwide (including Australia, United States and the United Kingdom). This announcement may include forward-looking statements that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "outlook", "forecast" and "guidance", or other similar words. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on the Company's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect the Company's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix's preclinical and clinical studies, and Telix's research and development programs; Telix's ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals, manufacturing activities and product marketing activities; the commercialisation of Telix's product candidates, if or when they have been approved; estimates of Telix's expenses, future revenues and capital requirements; Telix's financial performance; developments relating to Telix's competitors and industry; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. Exceptasrequiredbyapplicablelawsorregulations, Telixdoesnotundertaketopubliclyupdate orreviewanyforward- looking statements. Past performance cannot be relied on as a guide to future performance. Readers should read this announcement together with our material risks, as disclosed in our most recently filed reports with the ASX and on ourwebsite. 2023 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals and Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates (all rights reserved). [1]. Conversion to AUD is at the average exchange rate for the period. AUD$1 = US$0.68; AUD$1 = 0.64 [2]. Telix ASX disclosure 16 March 2023. Illuccix is now approved for use for the selection of patients with metastatic prostate cancer, for whom lutetium-177 (177Lu) PSMA-directed therapy is indicated, specifically lutetium Lu 177 vipivotide tetraxetan PSMA-directed therapy, marketed as Pluvicto (Pluvicto is a registered trademark of Novartis AG and/or its affiliates). [3]. 16 March 2023, joint media release with Isologic Innovative Radiopharmaceuticals. [4]. Pre-commercial sales are from investigational, clinical trial, magisterial and compassionate use in accordance with local laws and regulations (not as a commercial diagnostic imaging product sold for routine clinical practice). [5]. With a period of up to 60 days during the review for the applicant to reply to requests for additional information. [6]. Top line data released to ASX on 7 November 2022. [7]. Telix media release 20 February 2023. [8]. Telix ASX disclosure 22 March 2023. [9]. Telix media release 11 April 2023. [10]. Telix ASX disclosure 17 April 2023. [11]. Telix ASX disclosure 20 December 2021. [12]. Telix ASX disclosure 2 November 2021. [13]. Telix ASX disclosure 14 October 2022. [14]. Telix ASX disclosure 3 April 2023. "/>

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Singapore Star.

More Information
null in null

International

Section
UN climate agency gets 10 percent boost amid global budget cuts
UN climate agency gets 10 percent boost amid global budget cuts

BONN, Germany: Despite widespread belt-tightening across the United Nations, nearly 200 countries agreed this week to increase the...

Mexican President orders review of SpaceX environmental impact
Mexican President orders review of SpaceX environmental impact

MEXICO CITY, Mexico: Mexican President Claudia Sheinbaum said this week that her government is investigating possible environmental...

Historic ISS mission launches with crew from 4 different nations
Historic ISS mission launches with crew from 4 different nations

CAPE CANAVERAL, Florida: In a landmark flight for three nations and a veteran U.S. spacefarer, a four-member astronaut crew launched...

U.S. government sues Maryland court over pause in migrant deportations
U.S. government sues Maryland court over pause in migrant deportations

WASHINGTON, D.C.: In a striking escalation of tensions between the executive and judicial branches, the Trump administration has filed...

Thailand-Cambodia tensions rise as border rules tighten
Thailand-Cambodia tensions rise as border rules tighten

BANGKOK, Thailand: This week, Thailand implemented land border restrictions, including a ban on tourists traveling to Cambodia, as...

Alliance eyes major military buildup to counter Russia
Alliance eyes major military buildup to counter Russia

THE HAGUE, Netherlands: NATO is pressing ahead with a sweeping new defense spending target, calling on all 32 member nations to commit...

Business

Section
Euro, pound surge as U.S. rate cut odds grow after Powell hint
Euro, pound surge as U.S. rate cut odds grow after Powell hint

NEW YORK CITY, New York: The U.S. dollar tumbled this week, hitting its lowest levels since 2021 against the euro, British pound, and...

Sam’s Club fulfillment center to shut in Texas, jobs impacted
Sam’s Club fulfillment center to shut in Texas, jobs impacted

NEW YORK CITY, New York: Walmart is set to close a major Sam's Club fulfillment center in Fort Worth, Texas, as part of a shift in...

Meta wins lawsuit in California court over AI use of authors’ books
Meta wins lawsuit in California court over AI use of authors’ books

SAN FRANCISCO, California: A U.S. judge has dismissed a copyright lawsuit filed by 13 authors against Meta Platforms, the company that...

From 2028, top earners in Oman will face 5% income tax
From 2028, top earners in Oman will face 5% income tax

DUBAI, U.A.E: Oman is set to introduce a personal income tax as part of its strategy to reduce dependency on hydrocarbon revenues....

U.S. stocks surge despite Trump rift with Canada
U.S. stocks surge despite Trump rift with Canada

NEW YORK, New York - U.S. President Donald Trump dropped a bombshell on Friday announcing he had terminated trade talks with Canada....

United Steelworkers Union chief slams Trump over IRA move
United Steelworkers Union chief  slams Trump over IRA move

Federal officials, then-Governor of Indiana Eric Holcomb, union leaders, company representatives, and dozens of guests assembled at...